Estradiol and fibulin-1 inhibit motility of human ovarian-and breast- cancer cells induced by fibronectin

International Journal of Cancer

Volumn 75, Issue 4, 1998, Pages 654-658

  Hayashido, Yasutaka ^a,d   Lucas, Annick ^a   Rougeot, Christian ^a   Godyna, Svetlana ^b   Argraves, W Scott ^c   Rochefort, Henri ^a  

^a INSERM   (France)

^b HOLLAND LABORATORY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 4; ESTRADIOL; ESTROGEN RECEPTOR; FIBRONECTIN; FIBULIN; LAMININ; SCLEROPROTEIN;

ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL MOVEMENT; CHEMOTAXIS; ESTRADIOL; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBRONECTINS; HUMANS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032498551     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980209)75:4<654::AID-IJC26>3.0.CO;2-7     Document Type: Article

References (25)

1. AKIYAMA, S.K., OLDEN, K. and YAMADA, K.M., Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev., 14, 173-189 (1995).
2. ARGRAVES, W.S., TRAN, H., BURGESS, W.H. and DICKERSON, K., Fibulin is an extracellular-matrix and plasma glycoprotein with repeated domain structure. J. Cell Biol., 111, 3155-3164 (1990).
3. BALBONA, K., TRAN, H., GODYNA, S., INGHAM, K.C., STRICKLAND, D.K. and ARGRAVES, W.S., Fibulin binds to itself and to the carboxyl-terminal heparin-binding region of fibronectin. J. biol. Chem., 267, 20120-20125 (1992).
4. CAILLEAU, R., YOUNG, R., OLIVE, M. and REEVES, W.J., Breast-tumor cell lines from pleural effusions. J. nat. Cancer Inst., 53, 661-674 (1974).
5. CHAMBERS, A.F., MACDONALD, I.C. and SCHMIDT, E.E., Steps in tumor metastasis: new concepts from intravital videomicroscopy. Cancer Metastasis Rev., 14, 279-301 (1995).
6. CHIQUET-EHRISMANN, R., KALLA, P., PEARSON, C.A., BECK, K. and CHIQUET, M., Tenascin interferes with fibronectin action. Cell. 53, 383-390 (1988).
7. CLINTON, G., ROUGEOT, C., DERANCOURT, J., ROGER, P., DEFRENNE, A., GODYNA, S., ARGRAVES, W.S. and ROCHEFORT, H., Estrogens increase the expression of fibulin-1, an extracellular-matrix protein, secreted by human ovarian-cancer cells. Proc. nat. Acad. Sci. (Wash.), 93, 316-320 (1996).
8. DICKSON, R.B., MCMANAWAY, M.E. and LIPPMAN, M.E., Estrogen-induced factors of breast-cancer cells partially replace estrogen to promote tumor growth. Science, 232, 1540-1544 (1986).
9. GALTIER-DEREURE, F., CAPONY, F., MAUDELONDE, T. and ROCHEFORT, H., Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian-cancer cell line BG-1. J. clin. Enclocrinol. Metab., 75, 1497-1502 (1992).
10. GARCIA, M., DEROCQ, D., FREISS, G. and ROCHEFORT, H., Activation of estrogen receptor transfected into a receptor-negative breast-cancer cell line decreases the metastatic and invasive potential of the cells. Proc. nat. Acad. Sci. (Wash.), 89, 11538-11542 (1992).
11. GARCIA, M., DEROCQ, D., PLATET, N., BONNET, S., BROUILLET, J.P., TOUITOU, I. and ROCHEFORT, H., Both estradiol and tamoxifen decrease proliferation and invasiveness of cancer cells transfected with a mutated estrogen receptor. J. Steroid Biochem. mol. Biol., 59, 1-7 (1996).
12. GEISINGER, K.R., KUTE, T.E., PETTENATI, M.J., WELANDER, C.E., DENNARD, Y., COLLINS, L.A. and BERENS, M.E., Characterization of a human ovarian-carcinoma cell line with estrogen and progesterone receptors. Cancer, 63, 280-288 (1989).
13. HAY, E.D., Role of cell-matrix contacts in cell migration and epithelialmesencnymal transformation. Cell. Differ. Dev., 32, 367-375 (1990).
14. HUA, W., CHRISTIANSON, T., ROUGEOT, C., ROCHEFORT, H. and CLINTON, G.M., SKOV3 ovarian-carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and anti-estrogens. J. Steroid Biochem. mol. Biol., 55, 279-289 (1995).
15. LANGDON, S.P., HIRST, G.L., MILLER, E.P., HAWKINS, R.A., TESDALE, A.L., SMYTH, J.F. and MILLER, W.R., The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian-carcinoma cell lines. J. Steroid Biochem. mol. Biol., 50, 131-135 (1994).
16. LANGDON, S.P., LAWRIE, S.S., HAY, F.G., HAWKES, M.M., MCDONALD, A., HAYWARD, I.P., SCHOL, D.J., HILGERS, J., LEONARD, R.C. and SMYTH, J.F., Characterization and properties of nine human ovarian-adenocarcinoma cell lines. Cancer Res., 48, 6166-6172 (1988).
17. LIOTTA, L.A., STRACKE, M.L., AZNAVOORIAN, S.A., BECKNER, M.E. and SCHIFFMANN, E., Tumor cell motility. Semin. Cancer Biol., 2, 111-114 (1991).
18. PAN, T.C., KLUGE, M., ZHANG, R.Z., MAYER, U., TIMPL, R. and CHU, M.L., Sequence of extracellular mouse protein BM-90/fibulin and its calcium-dependent binding to other basement-membrane ligands. Europ. J. Biochem., 215, 733-740 (1993).
19. PRICE, J.E., POLYZOS, A., ZHANG, R.D. and DANIELS, M.D., Tumorigenicity and metastasis of human breast-carcinoma cell lines in nude mice. Cancer Res., 50, 717-721 (1990).
20. RAO, B.R. and SLOTMAN, B.J., Endocrine factors in common epithelial ovarian cancer. Endocr. Rev., 12, 14-26 (1991).
21. ROARK, E.F., KEENE, D.R., HAUDENSCHILD, C.C., GODYNA, S., LITTLE, C.D. and ARGRAVES, W.S., The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. J. Histochem. Cytochem., 43, 401-411 (1995).
22. ROCHEFORT, H., PLATET, N., HAYASHIDO, Y., DEROCQ, D., LUCAS, A., CUNAT, S. and GARCIA, M., Estrogen receptor mediated inhibition of cancer cell invasion and motility. An overview. J. Steroid Biochem. Mol. Biol., 67, (1998) (In press).
23. RODRIGUEZ, C., CALLE, E.E., COATES, R.J., MIRACLE-MCMAHILL, H.L., THUN, M.J. and HEATH, C.W, JR., Estrogen-replacement therapy and fatal ovarian cancer. Amer. J. Epidemiol., 141, 828-835 (1995).
24. SPENCE, S.G., ARGRAVES, W.S., WALTERS, L., HUNGERFORD, J.E. and LITTLE, C.D., Fibulin is localized at sites of epithelial-mesenchymal transitions in the early avian embryo. Dev. Biol., 151, 473-484 (1992).
25. VIGNON, F., CAPONY, F., CHAMBON, M., FREISS, G., GARCIA, M. and ROCHEFORT, H., Autocrine growth stimulation of the MCF7 breast-cancer cells by the estrogen-regulated 52K protein. Endocrinology, 118, 1537-1545 (1986).